Unaudited Standalone And Consolidated Results For the First Quarter Ended June 30, 2026

Ref: IIL/SE/2026/1108/01 Date: August 11, 2026 The Manager Listing Compliance Department Listing Compliance Department BSE Limited National Stock Exchange of India Limited (Through BSE Listing Centre) (Through NEAPS) Scrip Code: 532851 Symbol: INSECTICID Dear Sir/Madam, Re: Outcome of the Board Meeting This has reference to our letter no.: IIL/SE/2026/2107/01 dated July 21, 2026. The Board of Directors of the Insecticides (India) Limited/ the Company (“Board”), at their meeting held today i.e August 11, 2026 inter alia considered and approved the Un-audited Standalone and Consolidated Financial Results of the Company, for the Quarter ended June 30, 2026 along with Limited Review Report of M/s S S Kothari Mehta & Co., LLP and M/s Devesh Parekh & Co., Joint Statutory Auditor(s) of the Company. The Financial Results were reviewed and recommended by the Audit Committee. Accordingly, we enclose the following as Annexure  Un-audited Standalone and Consolidated Financial Results for the Quarter ended on June 30, 2026.  Limited Review Report of the Statutory Auditor(s) on the Un-audited Standalone and Consolidated Financial Results for the Quarter ended on June 30, 2026. A copy of the said results together with the Limited Review Report are also being made available on the website of the Company at www.insecticidesindia.com. The Board meeting commenced at 12:00 Noon (IST) and concluded at 02:30 PM (IST) You are requested to kindly take on records. Thanking You, For Insecticides (India) Limited (Sandeep Kumar) Company Secretary & CCO Encl: As above Insecticides (India) Limited CIN: L65991DL1996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - 110 033; Telefax.: 011-27679700 - 05; Website: www.insecticidesindia.com; E-mail: investor@insecticidesindia.com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 ("T" In Lacs, except EPS) Quarter Ended Year Ended SINo. Particulirs 30-06-- 2026 Jlll-g0.3z-d li?::) 30--0066--2 025| 31-03-2-02:0 26) (Unaudited)| (Refer note 5) (Unaudited), (Audited)) I |Revenue from operations 61,648.22 42,795.60 69,137.24 2,14,414.11 11 |Other Income 462.36 480.29 374.51 1,211.12 11 [Total Income (I+1T) 62,110.58 43,275.89 69,511.75 2,15,625.23 IV |Expenses (a) Cost of materials consumed 38,641.98 26,829.00 38,763.70 1,24,564.76 (b) Purchase of Stock-in-Trade 7,670.83 3,139.60 2,949.09 13,290.04 (¢) Changes in inventories of finished goods, work-in-progress and 6:39020) o e TOTT stock-in-trade (d) Employee benefits expense 4,498.34 3,641.99 4,105.82 15,984.90 (c) Finance costs 464.98 418.05 364.98 1,651.20 (f) Depreciation and amortization expense 959.27 932.43 727.76 3,521.60 7,638.91 6,334.52 7,507.92 28,039.55 ‘Total expenses 56,484.11 41,405.65 61,826.92 1,97,427.53 V |Profit before tax (I1I-1V) 5,626.47 1,870.24 7,684.83 18,197.70 VI |Tax Expense (1) Current Tax 1,574.27 76.56 1,839.48 4,224.13 (2) Deferred Tax (130.85) 357.31 115.30 391.83 Total Tax Expense 1,443.42 433.87 1,954.78 4,615.96 V1L [Profit for the period / Year (V-VI) 4,183.05 1,436.37 5,730.05 13,581.74 VIII |Other comprehensive income A [ltems that will not be reclassified to profit or loss (i) Changes in fair value of FVTOCI equity instruments (177.10) 328.87 27.09 407.98 (ii) Remeasurement of net defined benefit plans (31.25)) (17.11) (35.00) (122.11) (iii) Income tax relating to these items 49.12 (72.31) 2.50 (64.31) Other comprehensive income for the period / Year (net of tax) (159.23) 239.45 (5.41) 221.56 IX |Total comprehensive income for the period / Year (VII+VIII) 4,023.82 1,675.82 5,724.64 13,803.30 Paid up equity share capital (Face value of 10/- each) 2,909.78 2,909.78 2,909.78 2,909.78 Other Equity 5 - - 1,18,490.59 Earnings per share (of 210 each) (a) Basic 14.38 4.94 19.69 46.68 (b) Diluted 1438 4.94 19.69 46.68 (Note: EPS for respective quarters are not annualized) Insecticides (India) Limited CIN: L65991DL1996PLC083909; Regd. Office: 401-402, Lusa Tower, Azadpur Commercial Complex, Delhi - 110 033; Telefax.: 011-27679700 - 05; Website: www.insecticidesindia.com; E-mail: investor@insecticidesindia.com STATEMENT OF UNAUDITED STANDALONE FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 Notes: 1 The above Unaudited Standalone Financial Results have been published in accordance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The above results have been reviewed and| recommended by the Audit Committee and approved by the Board of Directors at their meeting held on August 11, 2026. The Statutory| Auditors have carried out a limited review of financial results. The Limited Review Report and Quarterly Financial Results are available on) the Stock Exchange website at www.bseindia.com, www.nseindia.com and on the Company's website www.insecticidesindia.com. T'he above Unaudited Standalone Financial Results have been prepared in accordance with the Indian Accounting Standard (Ind AS), the provisions of the Companies Act, 2013 ("the Act"), as applicable and guidelines issued by the Securities and Exchange Board of India ("SEBI"). The Ind AS are prescribed under Section 133 of the Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 2015 and subsequent amendments thereto. 3 The Company is in the business of manufacturing and distribution of Agro-Chemicals and accordingly has one business segment viz "Agro-| Chemicals" comprising of Technical & Formulation. 4 T'he Board of Directors of Insecticides (India) Limited in its meeting held on August 09, 2024 had approved the dissolution/ liquidation of its| wholly owned subsidary IIL Overseas DMCC, Dubai. 1IL. Overseas DMCC has filled the windup/ dissolution with DMCCA (Office of the] Registrar of Companies of Dubai Multi Commodities Centre Authority) and dissolution is approved vide its letter dated September 19, 2025. S The figures of the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year up) to March 31, 2026 and the unaudited published year-to-date figures up to December 31, 2025 being the date of the end of the third quarter of} the financial year which were subjected to a limited review. For and on behalf of the Board| Place: Delhi Mana}mg Director| Dat 11/08/2026 DIN : 00576872 SSKOTHARI MEHTA & CO.LLP DEVESH PAREKH & C0. CharteredAccountants Chartered Accountants Plot No.68,OkhlaIndustrial Area, Phase-I 675,Aggarwal CyberPlaza-2, New Delhi-110020 Netaji Subhash Place,Pitampura,Delhi-110034 Independent Auditor's Review Report on the Quarterly Unaudited Standalone FinancialResults ofthe Insecticides (India)Limited Pursuant to Regulation 33ofthe SEBI(ListingObligation andDisclosure Requirements) Regulations,2015, asamended TheBoard ofDirectors Insecticides (India)Limited Delhi Review Report on theUnaudited Standalone FinancialResults 1. We have reviewed the accompanying statement of Unaudited Standalone Financial Results of Insecticides (India)Limited (the "Company") for the quarter ended June 30,2026 ("theStatement") attached herewith, beingsubmittedby the Companypursuanttothe requirementofRegulation33ofthe SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,asamended (the"Listing Regulations"). 2. This statement which is the responsibility ofthe Company's management and approved by the Board of Directors, hasbeenpreparedinaccordancewiththe recognition andmeasurement principles laid down in the Indian Accounting Standards34,"Interim Financial Reporting",prescribed undersection 133 ofthe Companies Act,2013 read with the relevant rules thereunder and other accountingprinciples generally acceptedin India. Our responsibility isto expressaconclusionon the Statementbasedonour review. 3. We conducted our review ofthe Statement in accordancewith the Standard on Review Engagements (SRE)2410,“Review of Interim Financial Information Perform [Showing first 8,000 characters — download PDF for full document]